New groundbreaking research by Stanford researchers has shown to do something that was previously believed not possible: ...

U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices ...

Objective Although socioeconomic status has been linked to various rheumatoid arthritis (RA)-related outcomes, evidence on ...

According to data from Money and Healthy Paws, 66% of pet owners caring for chronically ill pets spend up to $250 a month to ...

IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...

Leading pain researchers at City St George’s, University of London are partnering with Paradigm Biopharmaceuticals, an Australian late-stage clinical development company, to test a drug that could ...

When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and ...

Pain pathways mediated by neurotrophin molecules have emerged as potential drug targets in OA. This phase II trial, testing a ...

Upadacitinib and certolizumab demonstrated greater efficacy in reducing signs of enthesitis in psoriatic arthritis (PsA) ...

Can-Fite Signed a Deal Worth up to $325M with the Veterinary Company VetbiolixRamat Gan, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite ...

A major analysis of nearly 10,000 patients shows that simple, non-drug treatments like knee braces, hydrotherapy, and exercise can significantly ease knee osteoarthritis symptoms. These approaches not ...

Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety ...